How Does Elevance Health Company Work?

Elevance Health Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

How does Elevance Health generate profit?

Elevance Health grew to roughly $171 billion operating revenue in 2024, serving over 48 million medical members and 100 million across services. Its scale spans commercial, Medicare, Medicaid, PBM and care services, driving diversified income and underwriting discipline.

Elevance earns via insurance underwriting, medical-cost management, pharmacy revenues through CarelonRx, and fee-based care services, balancing premium growth and expense control to protect margins.

How Does Elevance Health Company Work? It combines risk-bearing insurance, PBM operations, and care-management services to align revenue streams and control medical loss ratios. See Elevance Health Porter's Five Forces Analysis

Elevance Health operates an integrated payer-plus-services model combining risk-bearing insurance plans, ASO for employers, and a scaled Carelon platform to manage pharmacy, behavioral and complex care; the company serves commercial, Medicaid, Medicare Advantage/Part D, and ACA exchange members with data-driven care management and network contracting.

Integrated Payer-plus-Services

Risk-bearing plans (HMOs, PPOs, EPOs, POS) are combined with administrative services and Carelon capabilities to align incentives across care, pharmacy and behavioral health.

Scaled Carelon Platform

CarelonRx PBM, behavioral health, complex care management and analytics form a closed-loop platform integrating claims, pharmacy and clinical data for care steering and cost control.

Distribution & Customers

Distribution includes brokers, direct-to-employer sales, public-sector RFPs, ACA exchanges and Medicare brokers; membership circa 27–28 million commercial, 11–12 million Medicaid, 3.5–4.5 million Medicare/Part D, and 2.5–3.0 million individual seasonal.

Network & Scale

Network contracting covers over 1.7 million clinicians and 70,000+ facilities, enabling local market depth across 14 core states and bargaining power for competitive premiums.

Operations rely on actuarial pricing, underwriting, formulary management and rebate aggregation, utilization management, risk adjustment, digital engagement and targeted care management to control high-cost conditions and optimize total cost of care.

Value Drivers & Financial Metrics

Key differentiators include Blue-brand access, local market density, and a closed-loop data platform that drives lower trend and adherence improvements via PBM programs and value-based provider arrangements.

• Commercial medical loss ratio typically low-to-mid 80s%
• Consolidated MLR typically mid-80s%
• Administrative expense ratio in the low 8–9% range
• Provider value-based contracts and care management reduce avoidable admissions and total cost of care

Carelon’s integrated analytics and cross-source data aggregation steer members to high-value care, improve medication adherence through PBM programs, and support outcomes-based provider arrangements; see further strategic context in Marketing Strategy of Elevance Health.

Elevance Health SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Revenue Streams and Monetization Strategies for Elevance Health center on risk-based premiums, pharmacy services, administrative services, and growing care services, supported by investment income and strategic steerage across networks and products.

Risk-based Premiums

Risk-based premium revenue represents the largest stream, roughly 85–90% of total revenue. In 2024 total operating revenue was about $171B, with Medicare and Medicaid comprising an estimated 55–60% of premiums and Commercial the remainder.

ASO Fees and Stop-loss

Administrative services only fees and stop-loss premiums generate mid-to-high single-digit percent of revenue and a disproportionately higher share of operating margin due to capital-light economics and lower medical risk exposure.

Pharmacy Revenue (CarelonRx)

Pharmacy-related revenue is estimated at $30–40B annualized, driven by specialty drug spend (over 50% of pharmacy spend) and manufacturer rebates. Monetization occurs via spread, rebates, administrative fees, and specialty fulfillment margins.

Care Services and Other (Carelon Services)

Care management, behavioral health, analytics, and home/post-acute coordination contribute low- to mid-single-digit percent of revenue today, with expanding margins as value-based contracts scale and cross-selling increases.

Investment Income and Other

Investment income contributes low-single-digit percent of revenue and benefited from higher interest rates in 2023–2024, modestly supporting overall profitability.

Monetization Levers

Key levers include tiered benefits, steerage to preferred networks and specialty pharmacies, value-based provider contracts, and cross-selling Carelon into both insured and ASO clients.

Geography and product mix shape margins: membership skews toward dense networks in Blue states, product mix is shifting to higher-margin Commercial group, Medicare Advantage stabilized after 2024 adjustments, and Medicaid renewals are selective post-redeterminations; Elevance has tilted toward services growth and higher-quality membership, improving premium yield per member while keeping SG&A roughly flat.

Key Revenue & Strategic Highlights

Revenue composition and strategic actions that drive monetization across Elevance Health:

• Risk-based premiums remain dominant, forming roughly 85–90% of revenue and anchored by Medicare/Medicaid (~55–60%) and Commercial premiums.
• ASO and stop-loss provide mid-to-high single-digit revenue with higher operating margin due to lower capital intensity.
• CarelonRx pharmacy revenue ~$30–40B annualized; specialty drugs now >50% of pharmacy spend; monetization via spread, rebates, and specialty margins.
• Carelon Services expanding in value-based arrangements, adding low- to mid-single-digit revenue but improving margin profile over 2023–2025.
• Investment income adds low-single-digit support and benefited from 2023–2024 interest rate environment.
• Monetization tactics: plan design tiers, network and pharmacy steerage, provider value-based contracts, cross-selling of services, and focus on higher-margin membership.
• Operational trends: geographic mix concentrated in dense-network states, selective Medicaid book management after redeterminations, and emphasis on Commercial group growth and Carelon services.
• For context on company mission and strategy see Mission, Vision & Core Values of Elevance Health.

Elevance Health PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Key milestones, strategic moves, and competitive edge for Elevance Health trace a 2022 rebrand and rapid Carelon integration, targeted build‑out of pharmacy and behavioral services, government program recalibration through 2023–2025, and strengthened local market density that together underpin resilient margins and improved quality metrics.

Rebrand and platform integration

The 2022 rebrand to Elevance Health signaled a payer‑plus‑services strategy under Carelon, consolidating PBM and care services to drive cross‑portfolio synergies and integrated value delivery.

Carelon build‑out

Carelon scaled specialty pharmacy, integrated behavioral health and advanced analytics for risk stratification, and increased penetration into ASO clients, boosting non‑risk revenue streams.

Government programs recalibration

Elevance navigated 2023–2024 Medicaid redeterminations and implemented MA repricing and benefit redesign to address 2024 CMS rate pressures; MA margins showed improvement into late 2024 and early 2025.

Local market wins

Retention and expansion of large employer accounts plus select state Medicaid awards increased local density across 14 states, improving negotiating leverage and unit cost control.

Technology investments and outcomes continued to drive operational improvements and support the business model.

Technology, data and competitive edge

AI‑driven utilization management, fraud/waste/abuse detection, and pharmacy adherence platforms reduced avoidable utilization and helped stabilize Star Ratings into 2025.

• Blue‑brand trust and scale procurement lower unit medical and pharmacy costs.
• Vertical integration from benefits design through point‑of‑care intervention improves retention and trend management.
• Local market density in 14 states enables tighter unit cost management and stronger provider negotiation.
• Carelon’s services stack contributes to diversified revenue: commercial, Medicare Advantage, Medicaid, PBM and ASO services.

For further comparative context see Competitors Landscape of Elevance Health.

Elevance Health Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Elevance Health holds a top-three position among U.S. managed care firms by revenue and membership, with strong Blue-state share, employer loyalty, and expanding services through Carelon and ASO relationships; its Medicare Advantage scale is mid-single digits nationally but notably higher in core states, while Medicaid presence is selective and disciplined.

Industry Position

Elevance Health is a top-three U.S. managed care company by revenue and medical membership, competing with UnitedHealth Group, CVS/Aetna, Cigna, and Humana. It leads across many Blue states, has robust Commercial group share in its Blues footprint, and growing services relationships beyond insured members.

Market Share Details

Medicare Advantage market share is mid-single digits nationally but higher in core states; Medicaid participation is selective; ASO and services revenue via Carelon are expanding the non-risk earnings base. See Revenue Streams & Business Model of Elevance Health for deeper detail.

Key Risks

Primary risks include regulatory and rate uncertainty (CMS Star Ratings and Medicare risk adjustment changes), drug cost inflation including GLP-1 uptake, specialty pharmacy concentration, and PBM reform compressing rebate economics. Cybersecurity, operational risk, and litigation around prior authorization and network adequacy add pressure.

Medical Cost & Competition

Medical cost trend volatility from outpatient procedure rebounds and physician supply constraints can widen loss ratios; competition from national payers and disruptors pressures pricing and margins. Specialty pharmacy concentration and GLP-1 drug utilization are high-impact cost drivers.

Management outlook emphasizes disciplined growth: stabilize Medicare Advantage margins through 2025 plan design, pursue selective Medicaid bids, and accelerate Commercial and ASO wins while scaling Carelon services to improve margin mix.

Future Outlook & Financial Targets

Guidance centers on sustaining a conservative capital posture, expanding services margin, and returning capital to shareholders via buybacks and dividends while keeping leverage moderate.

• Target consolidated medical loss ratio around mid-80s%
• SG&A target near 8–9% of revenue
• Debt-to-capital profile maintained in the low- to mid-20s%
• Projected EPS growth in the high single to low double digits annually if targets met

Elevance Health Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔